Learn more about whether AtriCure, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...
Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management ...
Shares of medical tech company Masimo (NASDAQ:MASI) jumped 3.5% in the morning session after the company presented an upbeat ...
Masimo is a medical technology and infrastructure company that, in my opinion, seems very overvalued at the moment. Governm ...
Founded in 1989 to solve the "unsolvable problem" of accurate pulse oximetry during patient movement, Masimo (NASDAQ:MASI) ...
Fintel on MSN
BTIG maintains Masimo (MASI) buy recommendation
Fintel reports that on December 4, 2025, BTIG maintained coverage of Masimo (NasdaqGS:MASI) with a Buy recommendation.
Philips acquires SpectraWave as medtech deals increase in December, with AI-powered coronary imaging technology boosting ...
TipRanks on MSN
Masimo unveils long-term strategy at investor day
Masimo ( ($MASI) ) has shared an update. On December 3, 2025, Masimo Corporation held its 2025 Investor Day, where CEO Katie Szyman and other ...
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Dec. 5, 2025 ...
The protracted legal wrangling between Apple and health wearable company Masimo has resulted in a nominal win for the tech giant – but failed to achieve its objectives. Apple and Masimo have been ...
Medical device maker Masimo Corp. hosted its 2025 Investor Day at its Irvine headquarters, covering financial targets through 2028.
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Masimo ( (MASI) ) has provided an update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results